CDA and familial pancreatic carcinoma: On the other hand, as to expression in tumour tissues, Giovannetti et al (2006) reported that multivariate analysis failed to show any prognostic significance of CDA mRNA expression in 81 patients with pancreatic cancer receiving gemcitabine.